Evidence map›Paper›PMID 41449447›Full record

ArticlePilot and feasibility studies2025

Decision support training for chronic kidney disease dyads: the ImPart Study protocol.

Shena Gazaway, Rachel Wells, Orlando M Gutierrez, Andres Azuero, Alica Cole, Tamara Nix-Parker, Leslie Pitts, Claretha Lyas, Katina Lang-Lindsey, Richard Knight and 5 more

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pilot and feasibility studies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06173323 (An Optimization Trial of a Stakeholder-enhanced Intervention to Improve the Decisional Partnership of Chronic Kidney Disease Dyads), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06173323 narecruitingnot on this map

An Optimization Trial of a Stakeholder-enhanced Intervention to Improve the Decisional Partnership of Chronic Kidney Disease Dyads (IMPART)

TypeinterventionalSponsorUniversity of Alabama at BirminghamRan2024 to 2028Enrolled128ConditionsDecision Making, Shared, Family Caregiving, Chronic Kidney DiseaseArmsImPart - Improving Chronic Kidney Disease Decisional Partnerships
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Shena GazawaySchool of Nursing, University of Alabama at Birmingham, 1720 2nd Avenue South, NB 485C, Birmingham, AL, 35294, USA. gazaways@uab.edu.ORCID http://orcid.org/0000-0003-3674-6288
Rachel WellsSchool of Nursing, University of Alabama at Birmingham, 1720 2nd Avenue South, NB 485C, Birmingham, AL, 35294, USA.
Orlando M GutierrezNephrology Training and Research Center, University of Alabama at Birmingham, Birmingham, AL, USA.
Andres AzueroSchool of Nursing, University of Alabama at Birmingham, 1720 2nd Avenue South, NB 485C, Birmingham, AL, 35294, USA.
Alica ColeSchool of Nursing, University of Alabama at Birmingham, 1720 2nd Avenue South, NB 485C, Birmingham, AL, 35294, USA.
Tamara Nix-ParkerSchool of Nursing, University of Alabama at Birmingham, 1720 2nd Avenue South, NB 485C, Birmingham, AL, 35294, USA.
Leslie PittsSchool of Nursing, University of Alabama at Birmingham, 1720 2nd Avenue South, NB 485C, Birmingham, AL, 35294, USA.
Claretha LyasNephrology Training and Research Center, University of Alabama at Birmingham, Birmingham, AL, USA.
Katina Lang-LindseyDepartment of Social Work, Psychology & Counseling, Alabama A & M University, Normal, AL, USA.
Richard KnightAmerican Association of Kidney Patients, Tampa, FL, USA.
Patricia Pazant, Birmingham, AL, USA.
Neil GustafusonAlabama Kidney Foundation, Mobile, AL, USA.
Ann RayburnLegacy of Hope, Birmingham, AL, USA.
Ebele UmeukejeVanderbilt University Medical Center, Nashville, TN, USA.
J Nicholas OdomSchool of Nursing, University of Alabama at Birmingham, 1720 2nd Avenue South, NB 485C, Birmingham, AL, 35294, USA.

Funding

Investigator Development CoreP50MD017338 · NIMHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KATZMARZYK, PETER TODD · 2021 to 2025
$27.7M
MOVE Trial: MOtiVational Strategies to Empower African Americans to Improve Dialysis AdherenceR01DK133530 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Ebele M Umeukeje · 2022 to 2026
$3.1M
Optimizing an Early Palliative Care Intervention for Advanced HF PatientsR00NR019854 · NINR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WELLS, RACHEL D · 2023 to 2025
$747k
An Optimization trial of a stakeholder-enhanced intervention to improve the decisional partnership of Chronic Kidney Disease dyads using the multiphase optimization strategy: Project ImPart.K23DK134756 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Shena Gazaway · 2023 to 2026
$674k
NIDDK NIH HHS K23 DK134756NIDDK NIH HHS K23DK134756NIDDK NIH HHS R01 DK133530NIMHD NIH HHS P50 MD017338NINR NIH HHS R00 NR019854NINR NIH HHS R00NR019854
6 · The paper itself

Abstract

backgroundIndividuals living with stage 4 chronic kidney disease and their caregivers face multiple health-related decisions as the disease progresses. The ImPart (Improving the decision-making PARTnership of chronic kidney disease dyads), community-informed, factorial pilot trial intervention aims to train members of the dyad in skills to enhance decision support for patients.

methodsThis single-site pilot 2 DISCUSSION: This protocol outlines a pilot factorial trial, guided by the multiphase optimization strategy, to evaluate a community-engaged, co-developed decision-support intervention for individuals with stage 4 chronic kidney disease and their caregivers.

trial registrationNCT06173323.

Indexed as

Dyadic decision-makingFactorial trialKidney diseaseMultiphase optimization strategy

Identifiers

PMID41449447
PMCPMC12849292

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.